Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Ezio Zanon

Showing results (61-70 of 77) with videos related to

Pageof 8
Sort By:
Seminars in Thrombosis and Hemostasis|November 24, 2015
Cancers in Patients with von Willebrand Disease: A Survey from the Italian Association of Haemophilia CentresMassimo Franchini, Caterina Di Perna, Cristina Santoro, et al.
Blood Transfusion = Trasfusione Del Sangue|December 29, 2022
A multicenter, real-world experience with recombinant FXIII for the treatment of patients with FXIII deficiency: from pharmacokinetics to clinical practice. The Italian FXIII StudyEzio Zanon, Samantha Pasca, Gianluca Sottilotta, et al.
Blood Transfusion = Trasfusione Del Sangue|February 17, 2022
Acquired haemophilia A: Italian Consensus Recommendations on diagnosis, general management and treatment of bleedingAntonio Coppola, Massimo Franchini, Armando Tripodi, et al.
Thrombosis and Haemostasis|April 10, 2015
Benefits of prophylaxis versus on-demand treatment in adolescents and adults with severe haemophilia A: the POTTER studyAnnarita Tagliaferri, Giulio Feola, Angelo Claudio Molinari, et al.
Haematologica|April 5, 2008
The Italian AICE-Genetics hemophilia A database: results and correlation with clinical phenotypeMaurizio Margaglione, Giancarlo Castaman, Massimo Morfini, et al.
Haemophilia : the Official Journal of the World Federation of Hemophilia|October 23, 2020
Management of patients with severe haemophilia a without inhibitors on prophylaxis with emicizumab: AICE recommendations with focus on emergency in collaboration with SIBioC, SIMEU, SIMEUP, SIPMeL and SISETAntonio Coppola, Giancarlo Castaman, Rita C Santoro, et al.
Journal of Clinical Medicine|June 24, 2022
Real-World Clinical Outcomes and Replacement Factor VIII Consumption in Patients with Haemophilia A in Italy: A Comparison between Prophylaxis Pre and Post Octocog Alfa (BAY 81-8973)Paolo Angelo Cortesi, Giovanni Di Minno, Ezio Zanon, et al.
Seminars in Thrombosis and Hemostasis|February 1, 2021
ABO Blood Group and Inhibitor Risk in Severe Hemophilia A Patients: A Study from the Italian Association of Hemophilia CentersMassimo Franchini, Antonio Coppola, Cristina Santoro, et al.
Journal of Clinical Medicine|April 12, 2022
Intracranial Haemorrhage in Haemophilia Patients Is Still an Open Issue: The Final Results of the Italian EMO.REC RegistryEzio Zanon, Samantha Pasca, Francesco Demartis, et al.
Haemophilia : the Official Journal of the World Federation of Hemophilia|December 5, 2022
Laying the foundations for gene therapy in Italy for patients with haemophilia A: A Delphi consensus studyGiancarlo Castaman, Christian Carulli, Raimondo De Cristofaro, et al.
Pageof 8

Showing results (61-70 of 77) with videos related to

Sort By:
Pageof 8
Seminars in Thrombosis and Hemostasis|November 24, 2015
Cancers in Patients with von Willebrand Disease: A Survey from the Italian Association of Haemophilia CentresMassimo Franchini, Caterina Di Perna, Cristina Santoro, et al.
Blood Transfusion = Trasfusione Del Sangue|December 29, 2022
A multicenter, real-world experience with recombinant FXIII for the treatment of patients with FXIII deficiency: from pharmacokinetics to clinical practice. The Italian FXIII StudyEzio Zanon, Samantha Pasca, Gianluca Sottilotta, et al.
Blood Transfusion = Trasfusione Del Sangue|February 17, 2022
Acquired haemophilia A: Italian Consensus Recommendations on diagnosis, general management and treatment of bleedingAntonio Coppola, Massimo Franchini, Armando Tripodi, et al.
Thrombosis and Haemostasis|April 10, 2015
Benefits of prophylaxis versus on-demand treatment in adolescents and adults with severe haemophilia A: the POTTER studyAnnarita Tagliaferri, Giulio Feola, Angelo Claudio Molinari, et al.
Haematologica|April 5, 2008
The Italian AICE-Genetics hemophilia A database: results and correlation with clinical phenotypeMaurizio Margaglione, Giancarlo Castaman, Massimo Morfini, et al.
Haemophilia : the Official Journal of the World Federation of Hemophilia|October 23, 2020
Management of patients with severe haemophilia a without inhibitors on prophylaxis with emicizumab: AICE recommendations with focus on emergency in collaboration with SIBioC, SIMEU, SIMEUP, SIPMeL and SISETAntonio Coppola, Giancarlo Castaman, Rita C Santoro, et al.
Journal of Clinical Medicine|June 24, 2022
Real-World Clinical Outcomes and Replacement Factor VIII Consumption in Patients with Haemophilia A in Italy: A Comparison between Prophylaxis Pre and Post Octocog Alfa (BAY 81-8973)Paolo Angelo Cortesi, Giovanni Di Minno, Ezio Zanon, et al.
Seminars in Thrombosis and Hemostasis|February 1, 2021
ABO Blood Group and Inhibitor Risk in Severe Hemophilia A Patients: A Study from the Italian Association of Hemophilia CentersMassimo Franchini, Antonio Coppola, Cristina Santoro, et al.
Journal of Clinical Medicine|April 12, 2022
Intracranial Haemorrhage in Haemophilia Patients Is Still an Open Issue: The Final Results of the Italian EMO.REC RegistryEzio Zanon, Samantha Pasca, Francesco Demartis, et al.
Haemophilia : the Official Journal of the World Federation of Hemophilia|December 5, 2022
Laying the foundations for gene therapy in Italy for patients with haemophilia A: A Delphi consensus studyGiancarlo Castaman, Christian Carulli, Raimondo De Cristofaro, et al.
Pageof 8